Wilmington, DE, United States of America

Onur Atasoylu

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 8.1

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Onur Atasoylu: Innovator in JAK2 Inhibitors

Introduction

Onur Atasoylu is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific variants of JAK2, a protein associated with various diseases, including cancer. With a total of four patents to his name, Atasoylu's work is paving the way for new therapeutic options.

Latest Patents

Atasoylu's latest patents include innovative compounds that serve as JAK2 V617F inhibitors. The first patent focuses on substituted pyrrolo[2,3-d]pyrimidine compounds, which are designed to modulate the activity of the V617F variant of JAK2. These compounds hold promise for the treatment of various diseases, particularly cancer. The second patent details tricyclic urea compounds that also target the V617F variant of JAK2, further contributing to the potential treatment landscape for cancer patients.

Career Highlights

Atasoylu is currently associated with Incyte Corporation, a leading biopharmaceutical company. His work at Incyte has allowed him to collaborate with other talented scientists and contribute to groundbreaking research in the field of oncology. His dedication to innovation and research has established him as a key figure in the development of new therapeutic agents.

Collaborations

Atasoylu has worked alongside esteemed colleagues such as Wenqing Yao and Cheng-Tsung Lai. Their collaborative efforts have enhanced the research and development of JAK2 inhibitors, showcasing the importance of teamwork in scientific advancements.

Conclusion

Onur Atasoylu's contributions to the field of medicinal chemistry, particularly through his patents on JAK2 inhibitors, highlight his role as an influential inventor. His work continues to inspire advancements in cancer treatment and showcases the potential of innovative research in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…